Kevin Jackson, MD
Cardiovascular Disease · Durham, NCNPI 1952413189
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $45,060 of the $71,097 with a category attached, or 63.4%. Medtronic accounts for 74.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $28,443 and has fallen 96.5% since, to $995 in 2025. Among cardiovascular disease clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $348.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$53K
- Abbott$7K
- Boston Scientific$7K
- Acutus Medical, Inc.$1K
- Medical Device Business Services, Inc.$1K
- Alcon$432
- plus $1K from 6 others
Across 29 payments — averaging $7137.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$184K
- Atricure, Inc.$23K
What the payments were for
- Consulting fees$4,2656%
- Speaking & faculty fees$45,06063%
- Travel & lodging$15,34322%
- Food & beverage$6,4299%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 147 | $52,583 |
| Abbott | 12 | $7,307 |
| Boston Scientific | 18 | $7,276 |
| Acutus Medical, Inc. | 2 | $1,193 |
| Medical Device Business Services, Inc. | 4 | $1,151 |
| Alcon | 7 | $432 |
| Biosense Webster, Inc. | 5 | $394 |
| Stryker | 1 | $315 |
| Eyepoint US, Inc. | 2 | $206 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $142 |
| NEW World Medical,inc. | 1 | $67 |
| Carl Zeiss Meditec Cataract Technology Inc. | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$20,046
- ViewMate Intracardiac Echo$4,978
- EnSite Precision Cardiac Mapping System$2,015
- GENERAL - THERAPIES$1,942
- Carto 3$1,531
- ARCTIC FRONT ADVANCE$599
- CARDIOBLATE CRYOFLEX$443
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$422
- CASCADIA INTERBODY SYSTEM$315
- Hydrus Microstent$260
- PulseSelect$174
- Ensite Cardiac Mapping System$165
- SelectSecure$161
- AFFERA MAPPING SYSTEM$126
- YUTIQ$124
How this compares
$71,097 in reported general payments places this provider in the 90th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 402 | $469,183 |
| MultaqDronedarone Hcl | 100 | $116,131 |
| XareltoRivaroxaban | 89 | $113,174 |
| FarxigaDapagliflozin Propanediol | 29 | $25,348 |
| Dofetilide | 58 | $13,082 |
| Flecainide Acetate | 141 | $7,847 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 27 | $7,261 |
| Metoprolol Succinate | 181 | $2,821 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 126 | $2,789 |
| Amiodarone Hcl | 157 | $2,664 |
| Diltiazem 12hr ErDiltiazem Hcl | 12 | $2,086 |
| Propafenone Hcl | 20 | $899 |
| SotalolSotalol Hcl | 41 | $649 |
| Potassium Chloride | 17 | $549 |
| Verapamil ErVerapamil Hcl | 19 | $549 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Durham
- R WilliamsDurham$2.1M
- Marat FudimDurham$902K
- Jonathan PicciniDurham$767K
- Robert MentzDurham$489K
- Adrian HernandezDurham$409K
- Neha PagidipatiDurham$301K
- Joseph KissloDurham$283K
- Mitchell KrucoffDurham$281K
- Ankeet BhattDurham$258K
- Christopher GrangerDurham$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.